Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Bin‐Yan Zhong"'
Autor:
Zhi‐Cheng Jin, Jia‐Wei Zhou, Jian‐Jian Chen, Rong Ding, Bernhard Scheiner, Si‐Na Wang, Hai‐Liang Li, Qing‐Xia Shen, Qing‐Yun Lu, Yi Liu, Wei‐Hua Zhang, Biao Luo, Hai‐Bin Shi, Ming Huang, Ye‐Ming Wu, Chun‐Wang Yuan, Ming‐Sheng Huang, Jia‐Ping Li, Jian‐Bing Wu, Xiao‐Li Zhu, Bin‐Yan Zhong, Hai‐Feng Zhou, Yu‐Qing Wang, Shan‐Zhi Gu, Zhi‐Yi Peng, Chuan‐Sheng Zheng, Rui‐Bao Liu, Guo‐Hui Xu, Wei‐Zhu Yang, Ai‐Bing Xu, Dong‐Fang Liu, Xiaolong Qi, Yee Hui Yeo, Hai‐Dong Zhu, Yang Zhao, David J. Pinato, Fanpu Ji, Gao‐Jun Teng
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 6, Pp 2705-2716 (2024)
ABSTRACT Background Cancer cachexia can impact prognosis, cause resistance to anticancer treatments and affect the tolerability of treatments. This study aims to identify hepatocellular carcinoma (HCC) with cachexia by characterizing longitudinal bod
Externí odkaz:
https://doaj.org/article/4310ada6467f4124b79fc0f29fea9832
Autor:
Yi Dong, Lingling Yin, Jintao Huang, Di Hu, Jing Sun, Zhe Zhang, Zhihao Li, Bin-Yan Zhong, Ran Zhu, Guanglin Wang
Publikováno v:
Materials Today Bio, Vol 29, Iss , Pp 101367- (2024)
Transarterial radioembolization (TARE) is a well-established clinical therapy for the treatment of patients with intermediate to advanced hepatocellular carcinoma (HCC) or those who are ineligible for radical treatment. However, commercialized radioa
Externí odkaz:
https://doaj.org/article/b06927900b314afb9d1fc961b7221817
Autor:
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, for the CHANCE001 Investigators
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigat
Externí odkaz:
https://doaj.org/article/0be907c2391b401e85670015bfb6cca0
Autor:
Jin-Tao Huang, Shuai Zhang, Yi-Han Yang, Zi-Chen Zhang, Nan Jiang, Wan-Ci Li, Jian Shen, Bin-Yan Zhong, Xiao-Li Zhu
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Hepatocellular carcinoma (HCC) is one of the most common and deadly malignancies worldwide. Approximately, 80% of patients are initially diagnosed at intermediate or advanced stages, which means that curative therapies are unable to be performed. In
Externí odkaz:
https://doaj.org/article/80d15b09d3e641e4a4cbba9fb17e25f3
Autor:
Zhi Wang, Bin-Yan Zhong, Hui Dai, Qiu-Zhen Xu, Wei-Bin Yang, Xin Zhang, Chuan-Jun Xu, Jin-Er Shu, Biao Shi, Chu-Hui Zeng, Cheng Li, Jian-Song Ji, Yong-Gang Li, Gao-Jun Teng
Publikováno v:
Fundamental Research, Vol 1, Iss 2, Pp 111-116 (2021)
The present study aimed to establish a prognostic nomogram to stratify high-risk patients with Coronavirus Disease 2019 (COVID-19) who progressed from the nonsevere condition on admission to severe during hospitalization. This multicenter retrospecti
Externí odkaz:
https://doaj.org/article/ade2c15f954e426d8621de29d857d933
Autor:
Fei Yang, Gui-Li Xu, Jin-Tao Huang, Yu Yin, Wei Xiang, Bin-Yan Zhong, Wan-Ci Li, Jian Shen, Shuai Zhang, Jun Yang, Hong Peng Sun, Wan-Sheng Wang, Xiao-Li Zhu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundLocoregional therapy combined with systemic therapy can further improve the prognoses for HCC. However, the efficacy of TACE combined with ICIs and TKIs for HCC and whether this triple therapy can activate systemic immune response are still
Externí odkaz:
https://doaj.org/article/ee877308303c4344a4c9b590da36987e
Autor:
Fei Yang, Jun Yang, Wei Xiang, Bin-Yan Zhong, Wan-Ci Li, Jian Shen, Shuai Zhang, Yu Yin, Hong-Peng Sun, Wan-Sheng Wang, Xiao-Li Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
PurposeTo explore the safety and efficacy of transarterial chemoembolization (TACE) in combination with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) for the treatment of unresectable hepatocellular carcinoma (uHCC).Materi
Externí odkaz:
https://doaj.org/article/95e1e03cf9d540dd8903e7e0216126e1
Autor:
Zhi-Cheng Jin, Li Chen, Bin-Yan Zhong, Hai-Dong Zhu, Chu-Hui Zeng, Rui Li, Jin-He Guo, Shi-Cheng He, Gang Deng, Xiao-Li Zhu, Cai-Fang Ni, Gao-Jun Teng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeGiven that the novel coronavirus disease (COVID-19) pandemic has disrupted operations globally, an institution’s ability to repeat transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) has also been affected
Externí odkaz:
https://doaj.org/article/cb2cf17f753f4ad28436abff5eebac16
Autor:
Bin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, Lei Zhang, Zhong-Heng Hou, Xiao-Li Zhu, Ling Wen, Cai-Fang Ni
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Objectives: To use baseline variables to predict one-year disease control for patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) combined with sorafenib as initial treatment by applying a machine learning
Externí odkaz:
https://doaj.org/article/c18a8c91fca24278b9333e6f9d90c9ff
Autor:
Li Chen, Chen-Xi Yu, Bin-Yan Zhong, Hai-Dong Zhu, Zhi-Cheng Jin, Guang-Yu Zhu, Qi Zhang, Cai-Fang Ni, Gao-Jun Teng
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Purpose: To identify the independent risk factors for transarterial embolization (TACE) refractoriness and to develop a novel TACE refractoriness score and nomogram for predicting TACE refractoriness in patients with hepatocellular carcinoma (HCC).Me
Externí odkaz:
https://doaj.org/article/6441a458e73a47fb80bb268fbf1759b3